All News
Filter News
Found 564,920 articles
-
Tru-D SmartUVC to Exhibit at 2019 AHE Exchange
8/16/2019
Tru-D SmartUVC, a leader in the UVC disinfection space, will attend and exhibit at the 2019 AHE Exchange, August 21-24 in San Antonio, Texas.
-
Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference
8/16/2019
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), today announced that Dr. Michael Kaminer presented and discussed the company's Rapid Acoustic Pulse technology ("RAP") for the treatment of cellulite at the Controversies and Conversations Symposium, August 9-11, 2019 in San Francisco.
-
Le-Vel Hits The Rockies For Inaugural Leadership Retreat
8/16/2019
Le-Vel Brands, LLC, the world leader in human nutritional and cosmetic innovation, brought together 150 top Brand Promoters and their guests for its first-ever Leadership Retreat at the luxurious Ritz-Carlton Denver, July 26-28.
-
Lawsuit Exposes Alleged Efforts to Keep U.S. Drug Prices High by Blocking Information About Lower Priced Online Options
8/16/2019
according to a lawsuit filed this week by PharmacyChecker.com in the Southern District Court of New York, an alleged conspiracy involving front groups for Big Pharma is keeping these lower priced drugs out of reach of millions of Americans.
-
Sunnybrook Health Sciences Centre Treats its First Patient With Elekta Unity MR-Linac
8/16/2019
Clinical implementation of breakthrough technology that Sunnybrook scientists and physicians helped transform from concept to clinical practice [16-August-2019] TORONTO , Aug. 16, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre has treated its first patient using Elekta Unity, a transformative
-
Smile Direct Club Files Registration Statement with SEC for Proposed Initial Public Offering
8/16/2019
SmileDirectClub announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of its Class A common stock.
-
Crescent European Specialty Lending Announces Unitranche Financing for Hanson Wade Acquisition by Graphite Capital
8/16/2019
Crescent Capital Group LP announced that its European Specialty Lending strategy has provided unitranche financing to support the acquisition of Hanson Wade by U.K.-based private equity firm Graphite Capital.
-
Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2019 Results Presentation and Webcast
8/16/2019
Nordic Nanovector ASA announces that it will report its results for the second quarter and first half 2019 on Thursday, 22 August 2019.
-
In a brief announcement, AveXis said the Kaspar brothers have not been involved in any operations at AveXis since early May, seemingly ahead of the U.S. Food and Drug Administration’s approval of Zolgensma.
-
When you’re evaluating a job offer it can be hard to look past the salary. But if a company can’t budge on their budget, it's time to think about other things they may be able to offer you.
-
After Suspending Generics Spin-Off, Mallinckrodt Eyes Potential FDA Approval of Liver Disease Drug
8/15/2019
Mallinckrodt’s experimental drug terlipressin hit the mark in a late-stage liver disease trial. Mallinckrodt said terlipressin met its primary endpoint in reversing three components of hepatorenal syndrome type 1. -
Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome
8/15/2019
Under the terms of the deal, Utragenyx will pay GeneTx $20 million for an exclusive option to acquire GeneTx. -
The FDA approved Wakix for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
-
BioSpace Global Roundup, Aug. 15
8/15/2019
Biopharma companies from across the globe provide updates on their pipeline and business. -
According to a regulatory filing, Saunders will walk away with $14.9 million in cash and $23.6 million in equity, mostly stock based on performance.
-
Researchers at Arizona State University are experimenting with a compound that might prevent Alzheimer’s and other neurodegenerative diseases, such as Parkinson’s disease, and potentially Down syndrome.
-
TB Alliance became the first nonprofit organization to win regulatory approval from the U.S. Food and Drug Administration for a new drug aimed at treating some of the most drug-resistant forms of tuberculosis.
-
Tips to Help Prevent the Spread of Hepatitis A Virus
8/15/2019
National outbreak covers 29 states and nearly 24,000 cases
-
Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs
8/15/2019
Dr. Agopyan joins Marker from Kite Pharma, a subsidiary of Gilead Sciences, where she served as Director of Regulatory Affairs, Global Regulatory Lead.
-
Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results
8/15/2019
Revenue increased 3 percent to $117.4 million, the highest ever quarterly revenue reported; Gross orders increased to $97.2 million